Verastem Inc. diskutieren
Verastem Inc.
WKN: A3EHM3 / Symbol: VSTM / Name: Verastem / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
2,24 €
1,82 %
Buy Verastem Inc.
Verastem, Inc. (NASDAQ: VSTM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $3.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $36.00 price target on the stock, up previously from $24.00.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $36.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) is now covered by analysts at B. Riley. They set a "buy" rating and a $21.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Truist Financial Co. from $39.00 to $34.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $27.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $32.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Royal Bank of Canada from $32.00 to $16.00. They now have an "outperform" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Alliance Global Partners from $34.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Truist Financial Co. from $34.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at B. Riley from $21.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Royal Bank of Canada from $16.00 to $13.00. They now have an "outperform" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at HC Wainwright from $17.50 to $7.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Truist Financial Co. from $18.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat
Neueste Beiträge
StockNews_com in Concord Medical Serv. ADR diskutieren